Showing results (431-440 of 644) with videos related to

Sort By:
Pageof 65
The Journal of Biological Chemistry|June 12, 2002
Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injuryByung Hee Han, Daigen Xu, Junjeong Choi, et al.
Genes & Development|February 23, 2013
Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulationJasbir Dalal, Jee Hoon Roh, Susan E Maloney, et al.
Neuron|January 24, 2024
Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteinsMichael R Strickland, Michael J Rau, Brock Summers, et al.
Aging and Disease|June 25, 2024
Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain AxisLushuang Xie, Qiaofeng Wu, Kelin Li, et al.
Neurology|August 3, 2019
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosisSuzanne E Schindler, James G Bollinger, Vitaliy Ovod, et al.
Neurobiology of Aging|March 25, 2021
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25Omar H Butt, Justin M Long, Rachel L Henson, et al.
Science Translational Medicine|January 11, 2019
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's diseaseBrendan P Lucey, Austin McCullough, Eric C Landsness, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKatherine Gong, Jigyasha Timsina, Muhammad Ali, et al.
Molecular Neurodegeneration|October 19, 2019
Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in modelTien-Phat V Huynh, Chao Wang, Ainsley C Tran, et al.
Molecular Neurodegeneration|December 19, 2024
Microglial CD2AP deficiency exerts protection in an Alzheimer's disease model of amyloidosisLingliang Zhang, Lingling Huang, Yuhang Zhou, et al.
Pageof 65